
Keywords: ACVR2A; activin receptor II; BMPRII; bone morphogenetic protein-receptor type 2; CCB; calcium channel blocker; miRNA; microinterfering RNA; mPAP; mean pulmonary arterial pressure; NYHA; New York Heart Association; PAH; pulmonary arterial hypertension; PVR